Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsORALGeneric

EMPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE

EMPAGLIFLOZIN; METFORMIN HYDROCHLORIDE

Standard Dose
5MG;1GM
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Discontinued
Summary

Approval overview EMPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE is listed in Drugs@FDA under application 212198 (ANDA).

Review priority: STANDARD Marketing status: Discontinued Active ingredient EMPAGLIFLOZIN; METFORMIN HYDROCHLORIDE Form and strength TABLET;ORAL - 5MG;1GM Sponsor ZYDUS PHARMS Submission history Latest submission status date: 2024-08-13 00:00:00.

Structured Monograph

Clinical summary

Approval overview EMPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE is listed in Drugs@FDA under application 212198 (ANDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient EMPAGLIFLOZIN; METFORMIN HYDROCHLORIDE Form and strength TABLET;ORAL - 5MG;1GM Sponsor ZYDUS PHARMS Submission history Latest submission status date: 2024-08-13 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Discontinued
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.
EMPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE (EMPAGLIFLOZIN; METFORMIN HYDROCHLORIDE) | Drug Monograph | MedicHelpline